CSL is a top pharmaceutical company based in Melbourne, Australia
The CSL Group is a specialty biotechnology company with more than 90 years of experience in the development and manufacture of vaccines and plasma protein biotherapies.
Report: Partnering Deals and Alliances with CSL
CSL is a top pharmaceutical company based in Melbourne, Australia
The company was founded in 1916.
The CSL Group is a specialty biotechnology company with more than 90 years of experience in the development and manufacture of vaccines and plasma protein biotherapies.
CSL researches, develops, manufactures and markets products to treat and prevent serious human medical conditions.
The company has two core businesses; all focused on advancing innovations that provide better options and outcomes, enabling healthier lives.
Plasma Products – the company uses Human plasma to produce a wide range of life-saving medicines. The business also supports all aspects of the process from the collection and testing of donated plasma through to the production of a range of plasma-derived products.
The key businesses involved with plasma products include:
- CSL Behring: is a global provider of plasma-derived & recombinant products. It operate one of the world's largest plasma collection networks through CSL Plasma
- CSL Behring (Australia): is the chosen national plasma fractionator of Australia, New Zealand, Hong Kong, Malaysia, Singapore and Taiwan. It also manufacture and market in vitro diagnostic products through bioCSL Immunohaematology
Vaccines & Pharmaceuticals - the company manufactures and provides influenza vaccine globally. bioCSL also markets a comprehensive range of vaccines and antivenoms as well as a range of pharmaceutical products supplied by other manufacturers.
CSL has an active licensing venture investment and acquisition group charged with analysing and managing all incoming opportunities. CSL has a long history of partnering, building numerous collaborative partnerships more
CSL announced 38 partnering / licensing deals since 2005, with over 14 deals in 2008 alone. Analysis of the partnering deals shows a strong emphasis on partnering in influenza vaccine followed by partnerships for development of plasma products more
CSL has also announced 2 M&A deals since 2005, with the latest deal for the acquisition of Talecris Biotherapeutics being terminated more
Report: Partnering Deals and Alliances with CSL
Examples of recent partnering and licensing deals announced CSL can be viewed in Current Partnering's Partnering Deals and Alliances with CSL partnering activity review article.
Examples of recent M&A deals announced CSL can be viewed in Current Partnering's Partnering Deals and Alliances with CSL M&A activity review article.
Our report provides more detailed insight into the details of each deal. See Partnering Deals and Alliances with CSL
Available reports from Current Partnering
Report: Partnering Deals and Alliances with CSL
Report: Partnering Deals and Alliances with Big Pharma
Available resources for deal coverage for CSL
Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more
Read: more on CSL company profile, recent partnering, M&A and financing news and articles
Related
Report: Practical Guide to Finding Partners
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now
Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now
View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk
View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk